Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)
PRONTO-EYE
2 other identifiers
interventional
60
1 country
1
Brief Summary
This is a a type 3 hybrid effectiveness-implementation pilot study to evaluate the PRONTO-EYE intervention, a rideshare transportation program, in patients with diabetic retinopathy with Medicaid insurance on adherence to ophthalmology visits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2025
CompletedFirst Posted
Study publicly available on registry
December 22, 2025
CompletedStudy Start
First participant enrolled
February 3, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
February 27, 2026
February 1, 2026
5 months
December 17, 2025
February 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patients that adhere to their scheduled ophthalmology visits
Proportion of patients who attend their scheduled ophthalmology visit compared to pre-implementation historical controls.
Baseline up to 6 months
Secondary Outcomes (6)
Adoption of PRONTO-EYE
Assessed continuously throughout the up to 6-month feasibility trial, with a final summary at trial completion.
Appropriateness of PRONTO-EYE
Implementation outcomes will be assessed throughout the duration of the study
Feasibility of PRONTO-EYE
Assessed upon completion of the up to 6-month feasibility trial
Fidelity of PRONTO-EYE
Assessed continuously throughout the up to 6-month feasibility trial, with a final summary at trial completion.
Penetration of PRONTO-EyE
Assessed continuously throughout the up to 6-month feasibility trial, with a final summary at trial completion.
- +1 more secondary outcomes
Study Arms (1)
PRONTO-EYE rideshare intervention offered
EXPERIMENTALAll eligible patients are invited to participate in PRONTO-EYE, a rideshare transportation program designed to improve adherence to eye care visits among Medicaid patients with diabetic retinopathy. All eligible patients are included in this arm regardless of if they decide to use PRONTO-EYE or not.
Interventions
The PROgram for Non-emergency TranspOrtation (PRONTO) - EYE intervention is a rideshare transportation program designed for patients to get to and from their visits. The intervention includes the rideshare as well as a service blueprint of the offering and how all individuals in the health system interact with it.
Eligibility Criteria
You may qualify if:
- Established patient
- Medicaid insurance
- History of diabetic retinopathy
- Lives within 25 miles of the clinic
- English speaking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Illinois at Chicagolead
- National Eye Institute (NEI)collaborator
Study Sites (1)
UI Health
Chicago, Illinois, 60647, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Ophthalmology and Visual Sciences
Study Record Dates
First Submitted
December 17, 2025
First Posted
December 22, 2025
Study Start
February 3, 2026
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 1, 2027
Last Updated
February 27, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
There are no plans to make IPD available to other researchers.